LADR GmbH Medical Care Center Neuruppin operates interdisciplinary healthcare facilities led by licensed physicians, in particular medical care centers under § 95 SGB V. The MVZ offers a complete range of medical laboratory tests with more than 2,000 different examinations. The company earns the majority of its revenues from statutory and private health insurance and reported sales of €17,505,847.78 in fiscal year 2023 (previous year: 25,979 T€). The average number of employees in 2023 amounted to 129, of which 9 were physicians and 120 were administrative staff. LADR GmbH MVZ Neuruppin is a 100% subsidiary of ISG Intermed Service GmbH & Co. KG and is consolidated into the financial statements of ISG Intermed Holding GmbH & Co. KG. LADR GmbH Medizinisches Versorgungszentrum Neuruppin is a family business.
Betrieb von fachgebietsübergreifenden und durch approbierte Ärzte geleiteten Gesundheitseinrichtungen und insbesondere Medizinischen Versorgungszentren im Sinne des § 95 SGB V.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Neuruppin Local Court, HRB 8390 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Jan Kramer | Geschäftsführer(in) | Geesthacht |
| Tobias Kramer | Geschäftsführer(in) | Hamburg |
| Thomas Wolff | Geschäftsführer(in) | Hamburg |
Source: German Commercial Register (Handelsregister) Neuruppin Local Court, HRB 8390 (as of 30 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 27.06.2025 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 21.05.2012 | Company Name Change | LADR GmbH Medizinisches Versorgungszentrum Neuruppin |
| 21.05.2012 | Registered Seat Change | Neuruppin |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 24.02.2009 | Share Capital Set | — | 25.000 € |
Source: German Commercial Register (Handelsregister) Neuruppin Local Court, HRB 8390 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €17,975,345 | €249,411 | €6,246,932 | — |
| 2023 | €17,505,848 | €0 | €6,008,051 | — |
| 2022 | €25,979,118 | €3,450,362 | €6,000,376 | — |
| 2021 | €25,601,814 | €4,675,161 | €6,060,872 | — |
| 2020 | €19,274,172 | €1,246,833 | €5,896,890 | — |
| 2019 | Rohergebnis€11.9M2 | €0 | €5,888,447 | — |
| 2018 | Rohergebnis€11.9M2 | €523,629 | €5,839,679 | — |
| 2017 | Rohergebnis€12.2M2 | €594,605 | €6,712,865 | — |
| 2016 | Rohergebnis€11.5M2 | €0 | €6,664,356 | — |
| 2015 | Rohergebnis€11.7M2 | €0 | €6,597,340 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Neuruppin Local Court, HRB 8390 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €5,952,554 | 56.1% |
| Material Costs | €4,663,893 | 43.9% |
| Depreciation | €778 | 0.0% |
